<DOC>
	<DOC>NCT00979056</DOC>
	<brief_summary>The aim of the study is to investigate the efficacy of the prophylactic treatment with rifaximin to prevent travellers diarrhoea.</brief_summary>
	<brief_title>Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>Adults ≥ 18 and &lt; 65 years Good general condition (according to history and clinical examination) Written informed consent No pregnancy No breast feeding Efficacious contraception (e.g. oral, doublebarrier) during the study and 4 weeks after termination of the study No participation in other clinical trials 4 weeks before, during participation, and 4 weeks after participation in this study Planned travel period between 6 and 28 days Planned travel to South and Southeast Asia Planned time to arrival in South or Southeast Asia ≤ 24 hours Pregnancy Breast feeding Age &lt; 18 and ≥ 65 years No written informed consent Chronic gastrointestinal disease and/ or immune insufficiency Low general condition (according to history and clinical examination) Regular medication with gastrointestinal sideeffects and/or immunosuppressive medication Participation in other clinical trials 4 weeks before, during and 4 weeks after termination of the study No efficacious contraception Planned travel period &lt; 6 and &gt; 28 days Planned travel outside South and Southeast Asia Vaccination against cholera using DUKORAL within 12 months prior to inclusion Planned time to arrival in South or Southeast Asia &gt; 24 hours Known hypersensitivity against rifaximin or rifamycinderivatives in general Known lactose intolerance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Traveller's diarrhoea</keyword>
	<keyword>Prevention</keyword>
</DOC>